Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Inhaled Hydrogen Gas and Lung Transplant Damage in Rats

Inhaled Hydrogen Gas Therapy for Prevention of Lung Transplant-Induced Ischemia/Reperfusion Injury in Rats

Research hubs: Respiratory System · Cardiovascular System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Inhaled Hydrogen Gas Therapy for Prevention of Lung Transplant-Induced Ischemia/Reperfusion Injury in Rats
Evidence type
Animal study (rat)
Authors
Tomohiro Kawamura, Chien-Sheng Huang, Naobumi Tochigi, Sungsoo Lee, Norihisa Shigemura, Timothy R. Billiar, Meinoshin Okumura, Atsunori Nakao, Yoshiya Toyoda
Journal
Transplantation
Year
2010
Study Type
Rat
Delivery
Gas
Dose
2% H2 inhalation during surgery and 1 hr after reperfusion
H₂ concentration
2% H2
Outcome
Positive
Peer Reviewed
Yes
Cited by
152 (OpenAlex, as of November 2026)
Country
United States

TL;DR

Inhaling hydrogen gas during and after lung transplant surgery in rats significantly reduced lung damage and improved lung function.

Key Finding

Inhaled hydrogen gas (2% H2) significantly improved lung graft function and reduced injury markers in transplanted rat lungs, including better oxygen exchange and decreased oxidative stress and inflammation.

Summary

This study tested whether inhaled hydrogen gas could protect lung grafts from damage during transplantation in rats. When lungs are transplanted, they experience a period without blood flow (ischemia) followed by blood flow restoration (reperfusion), which causes injury through oxidative stress and inflammation. Rats that breathed 2% hydrogen gas during and after transplant surgery showed significantly better lung function, less oxidative damage, and reduced inflammation compared to rats breathing other gas mixtures.

Practical Takeaway

This is an early-stage animal study suggesting hydrogen gas may have protective effects during lung transplantation, but results cannot yet be applied to humans. Further research, including human clinical trials, would be needed to determine whether this approach could benefit lung transplant patients.

Abstract (excerpt)

Successful abrogation of ischemia/reperfusion (I/R) injury of lung grafts could significantly improve short- and long-term outcomes for lung transplant (LTx) recipients. Hydrogen gas has potent antioxidant and antiapoptotic properties and has been recently used in number of experimental…

Read the full abstract on PubMed